October

October 6, 2014

MiRNA-based Regenerative therapy for DM: MiRNA-182 promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 6/September/2014, 5.55 am

A recent study from the Mammalian Genetics Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, London, United Kingdom; and School of Medicine, King’s College London, […]
October 5, 2014

Treating cancer with a longevity-promoting drug: Acarbose, the widely used drug in the treatment of NIDDM, suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via down regulation of its target genes, 6/October/2014, 5.27 am

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the University of Colorado BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase […]
October 5, 2014

Natural product-based therapy for Human cancer: (6)-gingerol (6G), the pungent component of Ginger, inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 6/October/2014, 5.06 am

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold E, Somwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and the US National […]
October 5, 2014

Interleukin-based Differentiation therapy for Human Leukaemia: Interleukin-1β (IL-1β) functions as an anti-cancer barrier by promoting differentiation of leukaemic cells via up regulation of Histone methyl-transferase MLL4, 6/October/2014, 4.50 am

A recent study from the Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA shows that “DNA-damage-induced differentiation of leukaemic cells as an […]